Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Major

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
New Zealand Veterinary Journal|April 1, 1979
An in vitro study of the replication of Mycoplasma ovipneumoniaeR M Major, J K Clarke, M R Alley
British Journal of Clinical Pharmacology|May 1, 1984
Saliva concentrations of isosorbide dinitrate, isosorbide 2-mononitrate and isosorbide 5-mononitrateI W Taylor, R M Major, L F Chasseaud, et al.
Clinical Pharmacology and Therapeutics|May 1, 1984
Isosorbide 5-mononitrate kineticsR M Major, T Taylor, L F Chasseaud, et al.
Arzneimittel-Forschung|January 1, 1978
Plasma concentrations of isosorbide dinitrate after administration of increasing doses of a sustained-release formulation to human subjectsT Taylor, D A O'Kelly, R M Major, et al.
Arzneimittel-Forschung|January 1, 1983
[Pharmacokinetics of 14C-isosorbide dinitrate after administration in various sustained-release formulations]L F Chasseaud, T Taylor, R M Major, et al.
Biopharmaceutics & Drug Disposition|April 1, 1985
Bioequivalence of a sustained-release isosorbide dinitrate formulation at steady-stateT Taylor, L F Chasseaud, R M Major, et al.
Arzneimittel-Forschung|January 1, 1984
[Bioavailability of isosorbide-5-mononitrate from delayed-action formulations]T Taylor, R M Major, F C Leaf, et al.
Arzneimittel-Forschung|January 1, 1984
Metabolic fact of 14C-isosorbide 5-mononitrate in humansS G Wood, B A John, L F Chasseaud, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 21, 2006
Species differences in the pharmacokinetics and metabolism of reparixin in rat and dogI Midgley, K Fitzpatrick, S J Wright, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
New Zealand Veterinary Journal|April 1, 1979
An in vitro study of the replication of Mycoplasma ovipneumoniaeR M Major, J K Clarke, M R Alley
British Journal of Clinical Pharmacology|May 1, 1984
Saliva concentrations of isosorbide dinitrate, isosorbide 2-mononitrate and isosorbide 5-mononitrateI W Taylor, R M Major, L F Chasseaud, et al.
Clinical Pharmacology and Therapeutics|May 1, 1984
Isosorbide 5-mononitrate kineticsR M Major, T Taylor, L F Chasseaud, et al.
Arzneimittel-Forschung|January 1, 1978
Plasma concentrations of isosorbide dinitrate after administration of increasing doses of a sustained-release formulation to human subjectsT Taylor, D A O'Kelly, R M Major, et al.
Arzneimittel-Forschung|January 1, 1983
[Pharmacokinetics of 14C-isosorbide dinitrate after administration in various sustained-release formulations]L F Chasseaud, T Taylor, R M Major, et al.
Biopharmaceutics & Drug Disposition|April 1, 1985
Bioequivalence of a sustained-release isosorbide dinitrate formulation at steady-stateT Taylor, L F Chasseaud, R M Major, et al.
Arzneimittel-Forschung|January 1, 1984
[Bioavailability of isosorbide-5-mononitrate from delayed-action formulations]T Taylor, R M Major, F C Leaf, et al.
Arzneimittel-Forschung|January 1, 1984
Metabolic fact of 14C-isosorbide 5-mononitrate in humansS G Wood, B A John, L F Chasseaud, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 21, 2006
Species differences in the pharmacokinetics and metabolism of reparixin in rat and dogI Midgley, K Fitzpatrick, S J Wright, et al.
Pageof 1